pocketful logo light
pocketful logo light
Supriya Lifescience Ltd logo

Supriya Lifescience Ltd

NSE: SUPRIYA BSE: 543434

₹975.80

(1.34%)

Fri, 12 Jun 2026, 04:00 pm

mtf coin illustrationMTF 5x

Supriya Lifescience Share Price Live Chart

1 Day

(1.34%)

No Result Found

Summary

  • Market Cap (in Cr)

    7796.37

  • Net Profit (in Cr)

    187.96

  • P/B

    5.92

  • Sector P/E

    44.89

  • P/E

    31.42

  • EV/EBITDA

    21.53

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.79

  • ROCE (Industry)

    14.04

  • RONW (Industry)

    13.17

  • ROE

    20.74

  • ROCE

    27.43

  • Debt/Equity

    0.01

  • EPS (TTM)

    26.03

  • Dividend Yield

    0.10

  • Book Value

    148.82

  • Interest Cover

    138.28

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters68.3068.3068.3068.3068.30
FII5.165.205.466.787.19
DII5.705.015.224.864.26
Public20.8421.5021.0220.0620.26
Government00000

Read More

Technical Analysis

RSI

65.85

MACD

70.43

50 DMA

737.52

200 DMA

712.03

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic1473.201170.501069.60867.80766.90565.10262.40
Fibonacci1170.501054.87983.43867.80752.17680.73565.10
Camarilla1051.941024.19996.45867.80940.95913.21885.46

Pivots Level: Classic

R3

+605.40

1473.20

R2

+302.70

1170.50

R1

+201.80

1069.60

867.80
867.80
Pivot Point
LTP: 977.15

S1

-100.90

766.90

S2

-302.70

565.10

S3

-605.40

262.40

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    930.14

  • 20-EMA

    875.53

  • 30-EMA

    833.10

  • 50-EMA

    781.27

  • 100-EMA

    735.01

  • 200-EMA

    711.00

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
27 May 2026board-meetingsAccounts, Quarterly Results, Final Dividend
09 Feb 2026board-meetingsQuarterly Results
02 Sept 2025agm
05 Aug 2025dividendFinal Dividend - Rs. - 105 Sept 2025
04 Aug 2025dividendDividend - Re 1 Per Share05 Sept 2025
27 May 2025dividend₹1.00 Dividend /Share05 Sept 2025
13 Sept 2024agm
20 Aug 2024dividendAnnual General Meeting/Dividend - Rs 0.80 Per Share21 Sept 2024
28 May 2024dividend₹0.80 Dividend /Share21 Sept 2024
04 Sept 2023agm

Read More

Peer Comparison

Supriya Lifescience Ltd logo

Supriya Lifescience Ltd

Cipla Ltd logo

Cipla Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Read More

Supriya Lifescience Ltd About

Supriya Lifesciences is primarily engaged in manufacturing of Bulk Drugs and Pharmaceutical Chemicals.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2008

Headquarters

CEO

Satish Waman Wagh

Employees

Contact

Website icon

Website

http://www.supriyalifescience.com

Email icon

Email

cs@supriyalifescience.com

Phone icon

Phone

91-22-40332727

Location icon

Location

207/208 Udyog Bhavan, Sonawala Road Goregaon (East), Mumbai, Maharashtra, 400063

Read More

Supriya Lifescience Ltd Company History

YearHistory
2018
  • CEP (Certificate of Sustainability) was granted for Brompheniramine Maleate, Mepyramine Maleate and Ketamine Hydrochloride.
2020
  • Third time USFDA approval was granted.
2021
  • CEP (Certificate of Suitability) was granted for Pentoxifylline, Esketamine Hydrochloride and Salbutamol Sulphate.
  • NMPA approval was granted.
  • Health Canada approval was granted.
2022
  • Supriya Lifescience Limited signed a captive solar project agreement with Enrich Energy Pvt. Ltd.
2024
  • Supriya Lifescience Ltd inaugurated a state-of-the-art Module E production block at Lote Parshuram, Maharashtra.
  • Supriya Lifescience inaugurated a Rs 125 crore API production block at Lote Parshuram site.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
GRAVITON RESEARCH CAPITAL LLPbulkSell585068785.0222 Nov 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy585068784.7922 Nov 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy658285488.5912 Aug 2024
GRAVITON RESEARCH CAPITAL LLPbulkSell658285488.6112 Aug 2024
GRAVITON RESEARCH CAPITAL LLPbulkSell627793342.3208 Feb 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy627793342.2108 Feb 2024
GRAVITON RESEARCH CAPITAL LLPbulkBuy456665312.2626 Dec 2023
GRAVITON RESEARCH CAPITAL LLPbulkSell456665312.426 Dec 2023
GRAVITON RESEARCH CAPITAL LLPbulkSell403147248.4812 May 2023
GRAVITON RESEARCH CAPITAL LLPbulkBuy403147248.3812 May 2023

Read More

Supriya Lifescience Ltd News

Supriya Lifescience to meet investors on June 12

Supriya Lifescience will hold a virtual investor meeting on June 12, 2026. The presentation is available on the company website.

09 Jun 2026

companies

Supriya Lifescience Targets Over ₹1000 Crore Revenue by FY27

Supriya Lifescience has set an ambitious revenue target of over ₹1000 crore by FY27, signaling strong growth ambitions for the pharmaceutical company.

01 Jun 2026

companies

Supriya Lifescience board meets May 27

Supriya Lifescience board meets on May 27, 2026, to consider FY26 audited results and dividend. Trading window closed from April 1.

20 May 2026

companies

Supriya Lifescience Gets VAI Rating from USFDA

Supriya Lifescience Limited successfully completes USFDA inspection at its manufacturing facility with VAI rating, encountering only one minor issue during the regulatory review process.

23 Apr 2026

companies

Supriya Lifescience Gets VAI Rating from USFDA

Supriya Lifescience Limited successfully completes USFDA inspection at its manufacturing facility with VAI rating, encountering only one minor issue during the regulatory review process.

22 Apr 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number